rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Biocon Cmd Shaw

Rediff.com  »  News  »   Biocon Cmd Shaw

  News for Biocon Cmd Shaw

  • News
  • Business

Why 'Swastha Bharat' needs the e-health push

The low priority accorded to health care in India has resulted in a vicious cycle of disease, death and destitution. Over 63 million Indians slip into poverty every year as high health care costs......

Kiran Mazumdar-Shaw among 'top 100 talented' people

Biocon CMD Kiran Mazumdar-Shaw has been named in the world's top 100 ‘effective and talented’ people by US-based 'Scientific American' magazine, which hailed her contribution in......

Biotech sector may double to $5 bn by 2011

India's biotechnology sector is set to become a $10 billion industry by 2015, CMD of Biocon Ltd, Kiran Mazumdar-Shaw said on Tuesday. She expects the industry to grow to $5 billion by next year. In......

Infy must take cue from Cognizant, opt for share buyback: Pai

Mohandas Pai sought to look at the issue of founders raising questions as shareholder activism. Former Infosys board member T V Mohandas Pai has called on Infosys to announce a share buyback that......

Budget: A delicate balancing act with rural push

Jaitley's Budget has the potential to change the face of Modi's Bharat Arundhati BhattacharyaChairman, SBI The Budget is in line with the development priorities of the nation. Several initiatives......

India Inc backs Army action, rules out impact on economy

India Inc on Thursday rallied behind the Army’s move to conduct surgical strikes on terror launch pads across the Line of Control and said it was the time to act tough while ruling out......
  Web results for Biocon Cmd Shaw
Biocon’s CMD

The United States Foods and Drug Administration (USFDA) Oncologic Drugs Advisory Committee (ODAC) has recommended an approval of a biosimilar... ...

http://www.moneycontrol.com/news/business/odac\\u2019s-approval-takes-us-one-step-closer-to-usfda-nod-for-trastuzumab-biocon\\u2019s-cmd_9260741.html
Will try ask for re-inspection at the earliest, says Biocon

There appears to be a setback for Biocon as its biosimilars program hits a roadblock in Europe -- the drug products unit inspection done in March... ...

http://www.moneycontrol.com/news/business/will-tryask-for-re-inspection-atearliest-says-biocon_9235561.html
Pharma sector supply chain coping well after rollout

Time is needed to prepare for commercial launch of the new products: Biocon CMD Kiran Mazumdar Shaw ...

http://www.business-standard.com/article/economy-policy/gst-impact-pharma-sector-supply-chain-coping-well-after-rollout-117070600934_1.html
Kiran Mazumdar Shaw

In an interview to CNBC-TV18#39;s Shereen Bhan, Kiran Mazumdar-Shaw CMD, Biocon spoke about the goods and services tax (GST) and its impacts on her... ...

http://www.moneycontrol.com/news/economy/peoplevery-concerned-aboutcomplexitygst-kiran-mazumdar-shaw_9193001.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z